TECHNE CORP (TE1 BE) stock market data APIs
€43.2075
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
TECHNE CORP Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for TE1.BE.
Prev. Close
43.2075
Open
43.2075
High
43.2075
Low
43.2075
52 wk Range
40.6737-75.1867
Market Cap
16 216 M
Dividends (Yield)
0.0054
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get TECHNE CORP data using free add-ons & libraries
Get TECHNE CORP Fundamental Data
TECHNE CORP Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
TECHNE CORP News
New
Research Tools & Consumables Stocks Q2 Highlights: Bio-Techne (NASDAQ:TECH)
`` Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers. `` The life sciences subsector spe...
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
mdxhealth Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the ...
Here’s Why The Brown Capital Small Company Fund is Re-Evaluating Bio-Techne’s (TECH) Long-Term Growth Profile
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2025 investor letter. A copy of the letter can be download...
The three-year earnings decline is not helping Bio-Techne's (NASDAQ:TECH share price, as stock falls another 5.8% in past week
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But its virtually certain that sometimes you will buy stocks that fall ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
